US Lawyer Database

§ 26-4-203. [For Effective Date, See note.] Violations; Falsified Prescription Drugs

If the board finds that there is a reasonable probability that: A wholesale distributor, other than a manufacturer, has: Violated a provision of this article; or Falsified a pedigree, provided a falsified pedigree, or sold, distributed, transferred, manufactured, repackaged, handled, or held a counterfeit prescription drug intended for human use; The prescription drug at issue […]

§ 26-4-204. [For Effective Date, See note.] Prohibited Acts

It shall be unlawful for a person to perform or cause the performance of or aid and abet any of the following acts in this state: Selling, distributing, or transferring a prescription drug to a person that is not authorized to receive the prescription drug under the law of the jurisdiction in which the person […]

§ 26-4-205. [For Effective Date, See note.] Penalty

Notwithstanding Code Section 26-4-115, any person who engages without knowledge in the wholesale distribution of prescription drugs, including providing a falsified pedigree or other records, in violation of this article may be fined not more than $10,000.00. If a person engages in wholesale distribution of prescription drugs in violation of this article, including providing a […]

§ 26-4-170. Short Title

This article shall be known and may be cited as the “Nuclear Pharmacy Law.” History. Code 1981, § 26-4-170 , enacted by Ga. L. 1999, p. 277, § 10.

§ 26-4-210. Short Title

This article shall be known and may be cited as the “Safe Medications Practice Act.” History. Code 1981, § 26-4-210 , enacted by Ga. L. 2010, p. 195, § 1/HB 361.

§ 26-4-171. Definitions

As used in this article, the term: “Authentication of product history” means, but is not limited to, identifying the purchasing source, the ultimate fate, and any intermediate handling of any component of a radiopharmaceutical. “Board” means the State Board of Pharmacy. “Compounding of radiopharmaceuticals” means the addition of a radioactive substance to nonradioactive substances or […]

§ 26-4-211. Legislative Findings and Intent

The General Assembly finds and declares that: Medications are essential for the effective treatment and prevention of illness and disease, and medications, particularly dangerous drugs, are recognized to be complex chemical compounds which may cause untoward side effects, adverse reactions, and other undesirable and potentially harmful effects; Hospital pharmacists are highly trained in the therapeutic […]

§ 26-4-172. License Requirements Generally

All persons, firms, pharmacies, or corporations which receive, possess, transfer, or manufacture for sale or resale radiopharmaceuticals shall be licensed in accordance with the provisions of this article. No person may receive, acquire, possess, compound, or dispense any radiopharmaceutical except in accordance with the provisions of this article and the conditions of rules and regulations […]

§ 26-4-212. Definitions

As used in this article, the term: “Collaborate” means to work jointly with others as approved by an order from a physician member of the institution’s medical staff for care and treatment of the ordering physician’s patients or pursuant to a protocol established in accordance with medical staff policy. “Hospital pharmacist” means a pharmacist that […]